These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2953690)

  • 1. Effects of a new heterocyclic glucocorticoid, deflazacort (DFC), on the functions of lymphocytes from patients with rheumatoid arthritis (RA).
    Scudeletti M; Piccardo C; Piovano P; Imbimbo B; Indiveri F
    Int J Immunopharmacol; 1987; 9(2):133-9. PubMed ID: 2953690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
    Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies.
    Scudeletti M; Pende D; Barabino A; Imbimbo B; Grifoni V; Indiveri F
    Adv Exp Med Biol; 1984; 171():335-44. PubMed ID: 6232833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications.
    Ferrari A; Pasqualetti D; Del Bianco P; Gandolfo GM; Chistolini A; Mazzucconi MG
    Haematologica; 1991; 76(4):342-5. PubMed ID: 1794742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
    Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
    J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies.
    Coirini H; Flores D; Vega MC; Gonzalez Deniselle MC; De Nicola AF
    J Steroid Biochem Mol Biol; 1994 May; 49(1):43-9. PubMed ID: 8003438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions.
    Indiveri F; Scudeletti M; Pierri I; Traverso A; Cerri C; Ferrone S
    Cell Immunol; 1986 Jan; 97(1):197-203. PubMed ID: 2943425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
    Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
    Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.
    Imbimbo B; Tuzi T; Porzio F; Schiavetti L
    Adv Exp Med Biol; 1984; 171():241-56. PubMed ID: 6372394
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds.
    Lanza L; Scudeletti M; Monaco E; Monetti M; Puppo F; Filaci G; Indiveri F
    Ann N Y Acad Sci; 1999 Jun; 876():193-7. PubMed ID: 10415609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
    Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
    Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of deflazacort - a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone.
    Hahn BH; Pletscher LS; Muniain M
    J Rheumatol; 1981; 8(5):783-90. PubMed ID: 6458701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
    Musatov MI; Petrova ED; Konenkov VI
    Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.
    Førre O; Dobloug JH; Natvig JB
    Scand J Immunol; 1982 Feb; 15(2):227-31. PubMed ID: 6213027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
    Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of MHC Gene Expression by Glucocorticoid Hormones.
    Scudeletti M; Lanza L; Contini P; Puppo F; Indiveri F
    Int Arch Allergy Immunol; 1992; 99(2-4):295-301. PubMed ID: 34167222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.
    Langhoff E; Olgaard K
    Br J Clin Pharmacol; 1986 Feb; 21(2):125-9. PubMed ID: 3485440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.